Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
Cancer|July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancerSarah Everitt, Alan Herschtal, Jason Callahan, et al.
Journal of Medical Imaging and Radiation Oncology|July 28, 2021
Nodal metabolic tumour volume on baseline 18 F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapyRamin Alipour, Nick Bucknell, Mathias Bressel, et al.
Plos One|November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-RadiotherapyShu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
Journal of Medical Imaging and Radiation Oncology|October 10, 2013
Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastasesShankar Siva, Tomas Devereux, Tomas Kron, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
Leukemia & Lymphoma|April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failureAshley P Ng, Andrew Wirth, John F Seymour, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2023
Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 TrialNicholas W Bucknell, Tomas Kron, Alan Herschtal, et al.
British Journal of Cancer|July 21, 2017
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerMarliese Alexander, Rory Wolfe, David Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Pageof 9